Tatva Chintan Pharma Chem Limited

NSEI:TATVA Stock Report

Market Cap: ₹26.9b

Tatva Chintan Pharma Chem Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Chintan Shah

Chief executive officer

₹16.5m

Total compensation

CEO salary percentage30.8%
CEO tenure27.9yrs
CEO ownership23.8%
Management average tenureno data
Board average tenure15.6yrs

Recent management updates

Recent updates

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

Apr 04
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Jan 26
These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

May 10
Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Jul 28
Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Jun 17
Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

May 03
Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

Dec 06
Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

CEO Compensation Analysis

How has Chintan Shah's remuneration changed compared to Tatva Chintan Pharma Chem's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

₹304m

Dec 31 2023n/an/a

₹377m

Sep 30 2023n/an/a

₹459m

Jun 30 2023n/an/a

₹452m

Mar 31 2023₹17m₹5m

₹455m

Dec 31 2022n/an/a

₹460m

Sep 30 2022n/an/a

₹572m

Jun 30 2022n/an/a

₹825m

Mar 31 2022₹17m₹5m

₹959m

Dec 31 2021n/an/a

₹995m

Sep 30 2021n/an/a

₹976m

Jun 30 2021n/an/a

₹687m

Mar 31 2021₹14mn/a

₹523m

Mar 31 2020₹14mn/a

₹378m

Mar 31 2019₹14mn/a

₹205m

Compensation vs Market: Chintan's total compensation ($USD197.66K) is about average for companies of similar size in the Indian market ($USD275.29K).

Compensation vs Earnings: Chintan's compensation has been consistent with company performance over the past year.

CEO

Chintan Shah (49 yo)

27.9yrs

Tenure

₹16,503,252

Compensation

Mr. Chintan Nitinkumar Shah is the Managing Director and Chairman at Tatva Chintan Pharma Chem Limited and its Executive Director since June 12, 1996. He holds a bachelor’s degree in engineering, with a sp...

Board Members

NamePositionTenureCompensationOwnership
Chintan Shah
Chairman & MD27.9yrs₹16.50m23.84%
₹ 6.4b
Ajaykumar Patel
Whole Time Director27.9yrs₹16.50m24.01%
₹ 6.5b
Shekhar Somani
Whole Time Director27.9yrs₹16.50m24%
₹ 6.5b
Manher Desai
Non Executive Independent Director3.3yrs₹230.00kno data
Subhash Patel
Non Executive Independent Director3.3yrs₹250.00kno data
Avani Umatt
Non Executive Independent Director3.3yrs₹180.00kno data

15.6yrs

Average Tenure

50yo

Average Age

Experienced Board: TATVA's board of directors are seasoned and experienced ( 15.6 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.